CDKN1A and neoplasm: TLX interacts with HDAC3 and HDAC5, and in adult NSCs, TLX recruits these HDACs to cell cycle inhibitor p21Cip1/WAF1 and the Pten tumor suppressor, leading to their transcriptional repression.